Literature DB >> 17560272

The role of activation-induced deaminase in antibody diversification and chromosome translocations.

Almudena Ramiro1, Bernardo Reina San-Martin, Kevin McBride, Mila Jankovic, Vasco Barreto, André Nussenzweig, Michel C Nussenzweig.   

Abstract

Although B and T lymphocytes are similar in many respects including diversification of their antigen receptor genes by V(D)J recombination, 95% of all lymphomas diagnosed in the western world are of B-cell origin. Many of these are derived from mature B cells [Kuppers, R. (2005). Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 5, 251-262] and display hallmark chromosome translocations involving immunoglobulin genes and a proto-oncogene partner whose expression becomes deregulated as a result of the translocation reaction [Kuppers, R. (2005). Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 5, 251-262; Kuppers, R., and Dalla-Favera, R. (2001). Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20, 5580-5594]. These translocations are essential to the etiology of B-cell neoplasms. Here we will review how the B-cell specific molecular events required for immunoglobulin class switch recombination are initiated and how they contribute to chromosome translocations in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560272     DOI: 10.1016/S0065-2776(06)94003-6

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  37 in total

1.  Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes.

Authors:  Isaac A Klein; Wolfgang Resch; Mila Jankovic; Thiago Oliveira; Arito Yamane; Hirotaka Nakahashi; Michela Di Virgilio; Anne Bothmer; Andre Nussenzweig; Davide F Robbiani; Rafael Casellas; Michel C Nussenzweig
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

Review 2.  Activation-induced cytidine deaminase and aberrant germinal center selection in the development of humoral autoimmunities.

Authors:  Ahmad Zaheen; Alberto Martin
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia.

Authors:  Tanja Andrea Gruber; Mi Sook Chang; Richard Sposto; Markus Müschen
Journal:  Cancer Res       Date:  2010-09-28       Impact factor: 12.701

Review 4.  DNA damage and repair during lymphoid development: antigen receptor diversity, genomic integrity and lymphomagenesis.

Authors:  Nahum Puebla-Osorio; Chengming Zhu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 5.  Malleable immunoglobulin genes and hematopathology - the good, the bad, and the ugly: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

Authors:  Adam Bagg
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

6.  Ikaros in B cell development and function.

Authors:  Maclean Sellars; Philippe Kastner; Susan Chan
Journal:  World J Biol Chem       Date:  2011-06-26

7.  Colocalization of somatic and meiotic double strand breaks near the Myc oncogene on mouse chromosome 15.

Authors:  Siemon H Ng; Sarah A Maas; Petko M Petkov; Kevin D Mills; Kenneth Paigen
Journal:  Genes Chromosomes Cancer       Date:  2009-10       Impact factor: 5.006

8.  Regulation of activation-induced cytidine deaminase DNA deamination activity in B-cells by Ser38 phosphorylation.

Authors:  Uttiya Basu; Andrew Franklin; Bjoern Schwer; Hwei-Ling Cheng; Jayanta Chaudhuri; Frederick W Alt
Journal:  Biochem Soc Trans       Date:  2009-06       Impact factor: 5.407

9.  Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination.

Authors:  Isabelle Robert; Françoise Dantzer; Bernardo Reina-San-Martin
Journal:  J Exp Med       Date:  2009-04-13       Impact factor: 14.307

10.  Ikaros controls isotype selection during immunoglobulin class switch recombination.

Authors:  MacLean Sellars; Bernardo Reina-San-Martin; Philippe Kastner; Susan Chan
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.